<p>2025 年 4 月 14 日- 下午 4:35</p>
<p>紐約，紐約，2025 年 4 月 14 日（GLOBE NEWSWIRE）-- Denali Capital Acquisition Corp.（納斯達克：DECA）（“公司”）今天宣佈，2025 年 4 月 11 日，公司股東投票通過了對公司修訂和重述的備忘錄及章程（“章程”）的修訂，以將公司必須完成首次業務合併的日期從 2025 年 4 月 11 日延長至 2025 年 12 月 11 日，選擇每月延長一次，最多可延長八次，每次延長一個月（“延長”）。</p>
<p>公司還今天宣佈，2025 年 4 月 11 日，公司向公司的信託賬户（“信託賬户”）存入了 874.78 美元，代表未在特別股東大會上進行贖回的每股公眾股份 0.02 美元的金額。該存款通過公司向 Scilex Holding Company（納斯達克：SCLX，“Scilex”）發行的本金最高為 180,000 美元的現有可轉換票據進行融資，該票據不計利息，並在公司首次業務合併的生效日期或公司清算日期之前償還。在業務合併完成時，該票據可由 Scilex 自行決定轉換為公司 A 類普通股，轉換價格為每股 10.00 美元。預計未來對可轉換票據剩餘本金的提款將用於必要的未來一個月的延長，以提供額外時間讓公司完成業務合併。</p>
<p>關於投票結果的完整報告將以 8-K 表格提交給美國證券交易委員會（“SEC”）。</p>
<p><strong>關於公司</strong></p>
<p>Denali Capital Acquisition Corp.是一家空白支票公司，註冊為開曼羣島的豁免公司，旨在與一個或多個企業或實體進行合併、股份交換、資產收購、股份購買、重組或類似的業務合併。</p>
<p><strong>徵集參與者</strong></p>
<p>公司、其董事和高管及其他人員可能被視為在徵集公司股東關於延長的代理投票方面的參與者。有關公司董事和高管的信息可在其向 SEC 提交的 10-K 年度報告中找到。關於根據 SEC 規則可能被視為代理徵集參與者的人員及其直接和間接利益的描述包含在與股東大會相關的最終代理聲明（“最終代理聲明”）中。</p>
<p><strong>無報價或徵集</strong></p>
<p>本通訊不構成對任何證券的代理、同意或授權的徵集。本通訊也不構成出售或徵集購買任何證券的報價，也不應在任何州或司法管轄區進行證券的銷售，除非在該等司法管轄區的證券法下注冊或合格之前。證券的任何發行應僅通過符合 1933 年證券法第 10 條要求的招股説明書或其豁免進行。</p>
<p><strong>附加信息及獲取途徑</strong></p>
<p>2025 年 3 月 27 日，公司向 SEC 提交了最終代理聲明，以徵集股東大會的代理投票。公司投資者和證券持有者被敦促在最終代理聲明（包括任何修訂或補充）及公司向 SEC 提交的其他文件可用時仔細閲讀，因為這些文件將包含重要信息。投資者和證券持有者可以通過 SEC 維護的網站 www.sec.gov 或向公司的代理徵集人 Advantage Proxy, Inc.提出請求，獲取最終代理聲明（包括任何修訂或補充）及其他向 SEC 提交的文件的免費副本，地址為 P.O. Box 10904 Yakima, WA 98909，免費電話（877）870-8565 或收費電話（206）870-8565，電子郵件：ksmith@advantageproxy.com。</p>
<p><strong>前瞻性聲明</strong></p>
<p>本新聞稿包含涉及風險和不確定性的前瞻性聲明。前瞻性聲明受多種條件、風險和情況變化的影響，其中許多超出了公司的控制，包括在公司最近的 10-K 年度報告和向證券交易委員會提交的 10-Q 季度報告中的 “風險因素” 部分中列出的因素。公司明確否認任何義務或承諾，公開發布任何前瞻性聲明的更新或修訂，以反映公司對此的期望變化或任何聲明所基於的事件、條件或情況的變化。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RReU1qSTFOQ00yT0RZMk1qazFJelV3TURFeU16YzROUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RReU1qSTFOQ00yT0RZMk1qazFJelV3TURFeU16YzROUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png"/></p>
<pre><code> 聯繫信息：646-978-3133
</code></pre>

DECAU

DECA

DNQUF

DNQAF

SMNR

<p>Denali Capital Acquisition Corp.（納斯達克代碼：DECA）宣佈，股東批准將完成初始業務合併的截止日期從 2025 年 4 月 11 日延長至 2025 年 12 月 11 日。該延長允許每月最多延長八次。公司還向其信託賬户存入了 874.78 美元，這筆資金來自 Scilex Holding Company 的可轉換票據。將向美國證券交易委員會（SEC）提交一份 8-K 表格的當前報告，詳細説明投票結果</p>

<p>04/14/2025 - 04:35 PM</p>
<div class="lb-trans"><p>2025 年 4 月 14 日- 下午 4:35</p>
</div><p>NEW YORK, NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the &#34;Company&#34;) announced today that on April 11, 2025, the Company's shareholders voted in favor of approving amendments to the Company's amended and restated memorandum and articles of association (the &#34;Articles&#34;) to extend the date by which the Company must consummate an initial business combination from April 11, 2025 to December 11, 2025 by electing to extend the date to consummate an initial business combination on a monthly basis for up to eight times by an additional one month each time (the &#34;Extension&#34;).</p>
<div class="lb-trans"><p>紐約，紐約，2025 年 4 月 14 日（GLOBE NEWSWIRE）-- Denali Capital Acquisition Corp.（納斯達克：DECA）（“公司”）今天宣佈，2025 年 4 月 11 日，公司股東投票通過了對公司修訂和重述的備忘錄及章程（“章程”）的修訂，以將公司必須完成首次業務合併的日期從 2025 年 4 月 11 日延長至 2025 年 12 月 11 日，選擇每月延長一次，最多可延長八次，每次延長一個月（“延長”）。</p>
</div><p>The Company also announced today that on April 11, 2025, the Company deposited into the Company's trust account (the “Trust Account”) $874.78, representing the $0.02 per public share issued and outstanding that were not delivered for redemption in connection with the extraordinary general meeting.This deposit was funded via the Company’s existing convertible promissory note with a principal amount of up to $180,000 issued by the Company to Scilex Holding Company (Nasdaq: SCLX, “Scilex”), which bears no interest and is repayable on the earlier of the effective date of the consummation of the Company’s initial business combination or the date of the liquidation of the Company. Upon the closing of a business combination, the note is convertible, at Scilex’s discretion, into the Company’s Class A ordinary shares at a conversion price of $10.00 per share. Any future drawdowns of the remaining $ principal amount available under the convertible promissory note are expected to fund future one-month extensions as necessary to provide additional time for the Company to complete a business combination.</p>
<div class="lb-trans"><p>公司還今天宣佈，2025 年 4 月 11 日，公司向公司的信託賬户（“信託賬户”）存入了 874.78 美元，代表未在特別股東大會上進行贖回的每股公眾股份 0.02 美元的金額。該存款通過公司向 Scilex Holding Company（納斯達克：SCLX，“Scilex”）發行的本金最高為 180,000 美元的現有可轉換票據進行融資，該票據不計利息，並在公司首次業務合併的生效日期或公司清算日期之前償還。在業務合併完成時，該票據可由 Scilex 自行決定轉換為公司 A 類普通股，轉換價格為每股 10.00 美元。預計未來對可轉換票據剩餘本金的提款將用於必要的未來一個月的延長，以提供額外時間讓公司完成業務合併。</p>
</div><p>A Current Report on Form 8-K disclosing the full voting results will be filed with the U.S. Securities and Exchange Commission (the “SEC”).</p>
<div class="lb-trans"><p>關於投票結果的完整報告將以 8-K 表格提交給美國證券交易委員會（“SEC”）。</p>
</div><p><strong>About the Company</strong></p>
<div class="lb-trans"><p><strong>關於公司</strong></p>
</div><p>Denali Capital Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.</p>
<div class="lb-trans"><p>Denali Capital Acquisition Corp.是一家空白支票公司，註冊為開曼羣島的豁免公司，旨在與一個或多個企業或實體進行合併、股份交換、資產收購、股份購買、重組或類似的業務合併。</p>
</div><p><strong>Participants in the Solicitation</strong></p>
<div class="lb-trans"><p><strong>徵集參與者</strong></p>
</div><p>The Company, its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies from the Company's shareholders in respect of the Extension. Information regarding the Company's directors and executive officers is available in its Annual Report on Form 10-K filed with the SEC. Additional information regarding the persons who may, under the rules of the SEC, be deemed participants in the proxy solicitation and a description of their direct and indirect interests are contained in the definitive proxy statement relating to the Shareholder Meeting (the &#34;Definitive Proxy Statement&#34;).</p>
<div class="lb-trans"><p>公司、其董事和高管及其他人員可能被視為在徵集公司股東關於延長的代理投票方面的參與者。有關公司董事和高管的信息可在其向 SEC 提交的 10-K 年度報告中找到。關於根據 SEC 規則可能被視為代理徵集參與者的人員及其直接和間接利益的描述包含在與股東大會相關的最終代理聲明（“最終代理聲明”）中。</p>
</div><p><strong>No Offer or Solicitation</strong></p>
<div class="lb-trans"><p><strong>無報價或徵集</strong></p>
</div><p>This communication shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.</p>
<div class="lb-trans"><p>本通訊不構成對任何證券的代理、同意或授權的徵集。本通訊也不構成出售或徵集購買任何證券的報價，也不應在任何州或司法管轄區進行證券的銷售，除非在該等司法管轄區的證券法下注冊或合格之前。證券的任何發行應僅通過符合 1933 年證券法第 10 條要求的招股説明書或其豁免進行。</p>
</div><p><strong>Additional Information and Where to Find it</strong></p>
<div class="lb-trans"><p><strong>附加信息及獲取途徑</strong></p>
</div><p>On March 27, 2025, the company filed the Definitive Proxy Statement with the SEC in connection with its solicitation of proxies for the Shareholder Meeting. INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER DOCUMENTS THE COMPANY FILES WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Definitive Proxy Statement (including any amendments or supplements thereto) and other documents filed with the SEC through the web site maintained by the SEC atwww.sec.gov or by directing a request to the Company's proxy solicitor, Advantage Proxy, Inc., at P.O. Box 10904 Yakima, WA 98909, Toll-Free (877) 870-8565 or Collect (206) 870-8565, Email:ksmith@advantageproxy.com</p>
<div class="lb-trans"><p>2025 年 3 月 27 日，公司向 SEC 提交了最終代理聲明，以徵集股東大會的代理投票。公司投資者和證券持有者被敦促在最終代理聲明（包括任何修訂或補充）及公司向 SEC 提交的其他文件可用時仔細閲讀，因為這些文件將包含重要信息。投資者和證券持有者可以通過 SEC 維護的網站 www.sec.gov 或向公司的代理徵集人 Advantage Proxy, Inc.提出請求，獲取最終代理聲明（包括任何修訂或補充）及其他向 SEC 提交的文件的免費副本，地址為 P.O. Box 10904 Yakima, WA 98909，免費電話（877）870-8565 或收費電話（206）870-8565，電子郵件：ksmith@advantageproxy.com。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明</strong></p>
</div><p>This press release includes forward looking statements that involve risks and uncertainties. Forward-looking statements are subject to numerous conditions, risks and changes in circumstances, many of which are beyond the control of the Company, including those set forth in the &#34;Risk Factors&#34; section of the Company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.</p>
<div class="lb-trans"><p>本新聞稿包含涉及風險和不確定性的前瞻性聲明。前瞻性聲明受多種條件、風險和情況變化的影響，其中許多超出了公司的控制，包括在公司最近的 10-K 年度報告和向證券交易委員會提交的 10-Q 季度報告中的 “風險因素” 部分中列出的因素。公司明確否認任何義務或承諾，公開發布任何前瞻性聲明的更新或修訂，以反映公司對此的期望變化或任何聲明所基於的事件、條件或情況的變化。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RReU1qSTFOQ00yT0RZMk1qazFJelV3TURFeU16YzROUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTQyMjI1NCM2ODY2Mjk1IzUwMDEyMzc4NQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png" alt="" original-src="https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png"/></p>
<pre><code>Contact Info: 646-978-3133
</code></pre>
<div class="lb-trans"><pre><code> 聯繫信息：646-978-3133
</code></pre>
</div>

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination  | DECA Stock News

StockTitan

Denali Capital Acquisition - UNIT

Denali Capital Acquisition

DENALI CAPITAL ACQUISITION CORP UNIT 1 ORD A & 1 WT EXP (28/03/2027)

DENALI CAPITAL ACQUISITION CORP

Semnur Pharmaceuticals, Inc.

Scilex

Denali Capital Acquisition Corp.宣佈股東已批准延長完成業務合併的最後期限 | DECA 股票新聞